Scientific Sessions


PHA 2024 Scientific Sessions will bring together health care professionals from all disciplines to earn continuing education credit, network with other pulmonary hypertension professionals, learn about the latest research and discuss best practices for PH treatment and management. 

This year’s theme, “United Toward a Cure” ties into the PHA 2024 Conference theme, “Stronger Together.” PHA 2024 Scientific Sessions begin Thursday, Aug. 15, with poster hall presentations.





View the schedule at a glance.

View the full agenda.

Continuing Education Credit

Earn up to 15 AMA PRA Category 1 CreditsTM for attending Scientific Sessions and lightning-round abstract presentations. Continuing education credits are provided through the Pulmonary Hypertension Association and AffinityCE.

CE credits are available for physicians, physician assistants, nurse practitioners, nurses, and pharmacists. A general participation certificate is available for other attendees. Participants should claim only the credit commensurate with the extent of their participation in the activity.


PHA is no longer accepting abstract submissions.

Information for Authors of Accepted Abstracts

A horizontal poster board (8' in length x 4' in height) will be provided on-site for display in the conference Poster Hall. Posters should be slightly smaller than the board size.

At least one poster presenter must attend the conference, and all those who plan to attend must register.

PHA 2024 Poster Hall Schedule Date Time
Poster setup Thursday, Aug. 15  Noon-3:30 p.m.
Accredited poster Session/Unopposed poster viewing
(non-industry presenters only must attend)
Thursday, Aug. 15 4-5 p.m.
Lightning Round Poster Presentations Thursday, Aug. 15 5-6 p.m.
Poster Hall hours

Friday, Aug. 16


Saturday, Aug. 17

8 a.m.-5:30 p.m.


9 a.m.-1 p.m.

Poster removal Saturday, Aug. 17 1:30-5: p.m.


Accreditation Information

Continuing medical education credit will be available for attending and participating in the Poster Session on Thursday, Aug. 15. All presenting authors must submit their CVs, disclosures and signed continuing education agreements before presenting.

Industry Partners

PHA welcomes abstract submissions from industry partners. However, employees of ACCME-defined ineligible companies may not present their poster content during the established CME-accredited poster session. Authors who aren't employed by ineligible companies can be present and discuss their posters during this time.  Authors who are employees of ineligible companies must discuss their work outside of the accredited session.


As a reminder, PHA doesn’t reimburse for PHA 2024 registration, travel and hotel expenses. PHA greatly appreciates your participation in this volunteer activity and your interest in sharing your findings with conference attendees. At least one poster presenter must attend the conference, and all those who plan to attend must register. 

Early career professionals’ reception 

New to conference this year? PHA is excited to host a dedicated reception for early career professionals on Thursday evening, Aug. 15, at the JW Marriott Indianapolis lobby bar. This informal reception offers early career clinicians and researchers new to PHA the chance to network and meet new colleagues in the PH community. All PH professionals who are early in their careers (less than five years in practice) and want to enjoy a fun, casual meetup are encouraged to attend. If you have questions about the reception, please contact 

Research poster hall and lighting-round presentations 

Over 70 posters from clinicians and researchers across the PH care continuum will be presented during the PHA 2024 Scientific Sessions research poster hall sessions. The unopposed research poster hall will be held Thursday, Aug. 15, from 4-5 p.m., and the lightning-round presentations will be held from 5-6 p.m. Both sessions are accredited for continuing education credit.   
Featured presentations and abstract authors during the lightning round presentations include: 

“In vivo modeling of arteriovenous malformations and HHT-mimicry due to prospective PAH therapies,” presented by Massachusetts General Hospital and Harvard Medical School staff. “Right heart catheterization practice patterns in pulmonary hypertension diagnosis in the United States: A cross-sectional analysis,” presented by Francisco Soto, MD, MS, MBA, University of Tennessee Medical Center. 
“Elevated right ventricular systolic pressure is an independent predictor of mortality in pediatric pulmonary vein stenosis,” presented by Daiji Takajo, MD, MPH, Cincinnati Children's Hospital Medical Center. 
“PAH one-year survival prediction using integrative non-invasive lab and MRI variables,” presented by Max Cartwright, BA, The Ohio State University. 
“From breaths to beats: Pioneering PAH monitoring with end-tidal CO2,” presented by Navneet Kaur, MD, University of Southern California Keck School of Medicine. 
“TRPV4 contributes to angiotensin II-induced right ventricular hypercontractility in isolated hearts of type 3 pulmonary hypertensive mice,” presented by Andrew Behrmann, University of Missouri School of Medicine. 

Scientific Sessions Subcommittee

Rachel Hopper, MD (chair)
Teresa De Marco, MD, FACC, FHFSA
Jacqueline T. DesJardin, MD
Yuri Matusov, MD, FACP
Lori Reed, MSN, APRN, FNP-C
Allyson Rupp, MSW, LCSW, ACM-SW
Sandeep Sahay, MD, MSc
Navneet Singh, MD, MBA
Tina Stiyer, RN, BSN
Rachel Sullivan, MD
Scott H. Visovatti, MD

Registration Information